+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Digestive Remedies in France

  • PDF Icon

    Report

  • 26 Pages
  • September 2024
  • Region: France
  • Euromonitor International
  • ID: 323762
Digestive remedies in France is seeing robust current value rises in 2024, partly as a result of stock shortages leading to stronger price hikes, particularly in antacids. French consumers are also under increasing stress, brought about by global political events and a somewhat gloomy economic context, as well as the fuller return to offices and other work sites. These factors are pushing up stress levels and supporting a rise in reflux cases and thus demand for antacids.

The Digestive Remedies in France report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Diarrhoeal Remedies, IBS Treatments, Indigestion and Heartburn Remedies, Laxatives, Motion Sickness Remedies, Paediatric Digestive Remedies.

Data coverage: Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

  • Get a detailed picture of the Digestive Remedies market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.

Table of Contents

KEY DATA FINDINGS
2024 DEVELOPMENTS
  • Robust growth results from consumer stress and sharp price hikes
  • Tourism boost helps motion sickness remedies, while Johnson & Johnson leads by a slight margin
  • Focus on gut health and demand for probiotics present challenge to growth
PROSPECTS AND OPPORTUNITIES
  • Stress and ageing to maintain future category growth
  • PPIs faces concerns over possible product misuse
  • Natural alternatives pose threat to OTC remedies
CATEGORY DATA
  • Table 1 Sales of Digestive Remedies by Category: Value 2019-2024
  • Table 2 Sales of Digestive Remedies by Category: % Value Growth 2019-2024
  • Table 3 NBO Company Shares of Digestive Remedies: % Value 2020-2024
  • Table 4 LBN Brand Shares of Digestive Remedies: % Value 2021-2024
  • Table 5 Forecast Sales of Digestive Remedies by Category: Value 2024-2029
  • Table 6 Forecast Sales of Digestive Remedies by Category: % Value Growth 2024-2029
CONSUMER HEALTH IN FRANCE
EXECUTIVE SUMMARY
  • Consumer health in 2024: The big picture
  • 2024 key trends
  • Competitive landscape
  • Retailing developments
  • What next for consumer health?
MARKET INDICATORS
  • Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024
  • Table 8 Life Expectancy at Birth 2019-2024
MARKET DATA
  • Table 9 Sales of Consumer Health by Category: Value 2019-2024
  • Table 10 Sales of Consumer Health by Category: % Value Growth 2019-2024
  • Table 11 NBO Company Shares of Consumer Health: % Value 2020-2024
  • Table 12 LBN Brand Shares of Consumer Health: % Value 2021-2024
  • Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2019-2024
  • Table 14 Distribution of Consumer Health by Format: % Value 2019-2024
  • Table 15 Distribution of Consumer Health by Format and Category: % Value 2024
  • Table 16 Forecast Sales of Consumer Health by Category: Value 2024-2029
  • Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029
APPENDIX
  • OTC registration and classification
  • Vitamins and dietary supplements registration and classification
  • Self-medication/self-care and preventive medicine
  • Switches
DISCLAIMERDEFINITIONS
SOURCES
  • Summary 1 Research Sources